Archana Sadhu, M.D. | Source | Houston Methodist

“So we've had a lot of experience with the drug class. Ozempic is one of the newer of the agents," Sadhu said.

"If they are getting Ozempic and they're not a BMI (body mass index) of 27 or greater with a chronic medical condition that's related to obesity, or 30 or greater BMI, then they are being used off-label," Sadhu said.

“I think where the big gray zone is dispensing these sophisticated technology” without necessarily having a health care provider to interpret the results, says Archana Sadhu, M.D., an endocrinologist and director of the diabetes program at Houston Methodist Hospital.

“We’re not just talking about sugar. We’re talking about all the cascade of events that happen around consuming excess calories and that type of calories they are that directly play into sugar,” Dr. Sadhu explained.